2019 Outlook: Drug Competition Stays at Forefront of FDA Agenda

January 2, 2019

The Food and Drug Administration (FDA) will keep charging forward on increasing drug product competition in the new year while also revamping its medical device approval process, FDA leader Scott Gottlieb, M.D., told Bloomberg Law.

Related Stories